Jonathan Tegge
2023
In 2023, Jonathan Tegge earned a total compensation of $2.1K as Former Interim Chief Financial Officer at InMed Pharmaceuticals.
Compensation breakdown
| Option Awards | $2,100 |
|---|---|
| Total | $2,100 |
Tegge received $2.1K in option awards, accounting for 100% of the total pay in 2023.
Rankings
In 2023, Jonathan Tegge's compensation ranked 2,758th out of 2,770 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,758 out of 2,770 | 0th |
Division Manufacturing | 1,512 out of 1,516 | 0th |
Major group Chemicals And Allied Products | 853 out of 855 | 0th |
Industry group Drugs | 819 out of 821 | 0th |
Industry Pharmaceutical Preparations | 588 out of 590 | 0th |
Source: SEC filing on October 28, 2024.
Tegge's colleagues
We found four more compensation records of executives who worked with Jonathan Tegge at InMed Pharmaceuticals in 2023.
2023
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2023
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
2023
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2023
Eric Hsu
InMed Pharmaceuticals